Publication Name	World Journal of Clinical Cases
Manuscript ID	80573
Country	China

Category	Respiratory System
Manuscript Type	Case Report
Article Title	Envafolimab combined with chemotherapy in the treatment of combined small cell lung cancer: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Mei-Hong Liu, Yan-Xia Li and Zhuo Liu
Funding Agency and Grant Number	Funding Agency Grant Number the Foundation of Science and Technology Bureau of Dalian 2021JJ13SN70
Corresponding Author	Zhuo Liu, PhD, Doctor, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Dalian Medical University, No. 222 Zhongshan Road, Dalian 116011, Liaoning Province, China. liuzhuo@firstosp-dmu.com
Key Words	Combined small cell lung cancer; Envafolimab; Carboplatin; Etoposide; Prognosis; Case report
Core Tip	Combined small cell lung cancer (C-SCLC) is a special subtype of small cell lung cancer, which is relatively rare, aggressive, prone to early metastasis, and has a poor prognosis. With the development and progress of immunotherapy, several clinical studies have shown that programmed death ligand-1 combined with chemotherapy can effectively prolong the progression-free survival and median overall survival of patients with extensive stage small cell lung cancer, but its efficacy in C-SCLC is not exact. In this paper, we report a patient with extensive stage C-SCLC who was treated with envafolimab combined with carboplatin and etoposide with preliminary anti-tumor activity, safety and tolerability.
Citation	Liu MH, Li YX, Liu Z. Envafolimab combined with chemotherapy in the treatment of combined small cell lung cancer: A case report. World J Clin Cases 2023; 11(5): 1115-1121

Received	2022-10-24 08:23
Peer-Review Started	2022-10-04 04:04
To Make the First Decision
Return for Revision	2022-12-19 07:27
Revised	2023-01-08 10:24
Second Decision	2023-01-20 03:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-01-20 05:54
Articles in Press	2023-01-20 05:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-02-02 16:06

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com